By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Antineoplastic combinations > Kisqali femara co-pack 200 mg-2.5 mg dose
Antineoplastic combinations

Kisqali femara co-pack 200 mg-2.5 mg dose

https://themeditary.com/drug/kisqali-femara-co-pack-200-mg-2-5-mg-dose-4091.html
Medically Reviewed by Glamora Samuels, MD TheMediTary.Com | Reviewed: Aug 05, 2023  Additional Content by TheMediTary.Com

Generic name: letrozole and ribociclib [ let-roe-zol-and-rye-boe-sye-klib ]

Drug class: Antineoplastic combinations

Dosage form: kit

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Kisqali femara co-pack 400 mg-2.5 mg dose, Kisqali femara co-pack 600 mg-2.5 mg dose, Letrozole and ribociclib

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Kisqali femara co-pack 200 mg-2.5 mg dose?

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose are used together in combination to treat HR-positive, HER2-negative breast cancer.

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose is used when the cancer has spread to other parts of the body (metastatic).

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose are two different medicines that are packaged together. Letrozole tablets are yellow and ribociclib tablets are violet.

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose may also be used for purposes not listed in this medication guide.

Warnings

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose can cause a serious heart rhythm or lung problem. Call your doctor at once if you have fast or pounding heartbeats, severe dizziness, chest pain, or shortness of breath.

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose may also affect your liver or blood cells. Tell your doctor if you have right-sided stomach pain, tiredness, flu-symptoms, easy bruising or bleeding, dark urine, or yellowing of the skin or eyes.

This medicine may also cause a severe skin reaction. Get emergency medical help if you have a fever, sore throat, burning eyes, skin pain, or red or purple skin rash with blistering and peeling.

How should I use Kisqali femara co-pack 200 mg-2.5 mg dose

Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.

It is best to take Kisqali Femara Co-Pack 200 mg-2.5 mg Dose in the morning, but take it at the same time each day. You may take Kisqali Femara Co-Pack 200 mg-2.5 mg Dose with or without food.

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose is given in a 28-day treatment cycle. On days 1 through 21, you will take both ribociclib and letrozole together at the same time each day. During the last 7 days you will take only letrozole each day.

Your doctor may occasionally change the number of tablets in your dose. Follow all dosing instructions very carefully.

Swallow each tablet whole and do not crush, chew, or break it. Do not take any tablet that is broken or cracked.

If you vomit shortly after taking a tablet, do not take another dose. Wait until your next scheduled dose time to take the medicine again.

This medicine can cause a serious heart rhythm or lung problem. Call your doctor at once if you have fast or pounding heartbeats, severe dizziness, or trouble breathing, and shortness of breath.

You will need frequent medical tests while taking Kisqali Femara Co-Pack 200 mg-2.5 mg Dose. Your cancer treatments may be delayed based on the results of these tests.

Do not change your dose or stop taking this medicine without your doctor's advice.

Store each medicine in its original container at room temperature, away from moisture and heat.

Detailed Kisqali Femara Co-Pack dosage information
Kisqali femara co-pack 200 mg-2.5 mg dose Dosage information (more detail)

Before Taking

You should not use this medicine if you are allergic to letrozole (Femara) or ribociclib (Kisqali).

Your doctor will perform medical tests to make sure you do not have conditions that would prevent you from safely using this medicine.

Tell your doctor if you have any signs of infection, such as fever or chills, or if you have ever had:

  • heart disease, heart failure;

  • a heart attack;

  • heart rhythm problems, including slow heartbeats;

  • long QT syndrome;

  • low levels of calcium, phosphorus, potassium, or magnesium in your blood; or

  • liver disease.

If you have not gone through menopause, you may need an additional hormonal medication while taking Kisqali Femara Co-Pack 200 mg-2.5 mg Dose. Tell your doctor if you have begun having symptoms of menopause such as irregular menstrual periods, hot flashes, night sweats, sleep problems, or vaginal dryness.

You may need to have a negative pregnancy test before starting this treatment.

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose may harm an unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 3 weeks after your last dose. Tell your doctor right away if you become pregnant.

This medicine may affect fertility (ability to have children) in both men and women. However, it is important for women to use birth control to prevent pregnancy because Kisqali Femara Co-Pack 200 mg-2.5 mg Dose may harm the baby if a pregnancy does occur.

You should not breastfeed while using this medicine and for at least 3 weeks after your last dose.

What happens if I miss a dose?

Skip the missed dose and use your next dose at the regular time. Do not use two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Kisqali femara co-pack 200 mg-2.5 mg dose?

Grapefruit may interact with Kisqali Femara Co-Pack 200 mg-2.5 mg Dose and lead to unwanted side effects. Avoid the use of grapefruit products.

Kisqali femara co-pack 200 mg-2.5 mg dose side effects

Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose may cause serious side effects. Call your doctor at once if you have:

  • trouble breathing, shortness of breath, cough with or without mucus, chest pain;

  • fast or pounding heartbeats, fluttering in your chest, and sudden dizziness (like you might pass out);

  • liver problems--loss of appetite, right-sided stomach pain, tiredness, easy bruising or bleeding, dark urine, jaundice (yellowing of the skin or eyes);

  • low red blood cells (anemia)--pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet; or

  • low white blood cell counts--fever, mouth sores, skin sores, sore throat, cough, trouble breathing.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects of Kisqali Femara Co-Pack 200 mg-2.5 mg Dose may include:

  • low white blood cells, infections;

  • anemia;

  • tiredness;

  • nausea, vomiting, diarrhea, constipation;

  • headache;

  • rash;

  • back pain; or

  • hair loss.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Kisqali femara co-pack 200 mg-2.5 mg dose Side Effects

What other drugs will affect Kisqali femara co-pack 200 mg-2.5 mg dose?

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose can cause a serious heart problem. Your risk may be higher if you also use certain other medicines for infections, asthma, heart problems, high blood pressure, depression, mental illness, cancer, malaria, or HIV.

Many drugs can affect Kisqali Femara Co-Pack 200 mg-2.5 mg Dose. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any medicine you start or stop using.

More about Kisqali femara co-pack 200 mg-2.5 mg dose (Letrozole and ribociclib [ let-roe-zol-and-rye-boe-sye-klib ])

Dosage information
Kisqali femara co-pack 200 mg-2.5 mg dose Side Effects
During pregnancy
Kisqali Femara Co-Pack Prescribing Information
Drug images
Side effects
Drug class: Antineoplastic combinations

Patient resources

Kisqali Femara Co-Pack

Related treatment guides

Breast Cancer
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by